Wunderman wins AstraZeneca's Faslodex

Share this article:

Pharmaceuticals marketer AstraZeneca has tapped Wunderman New York to launch a consumer campaign for Faslodex, a later-stage breast cancer prescription drug for women.

The direct marketing agency competed with CommonHealth and Digitas' Medical Broadcasting Company agency for the account. Billings were not disclosed.

"This helps us broaden our portfolio with their oncology division," said Steve Zammarchi, president/CEO of Wunderman New York. "We have to create awareness for the product in the direct-to-consumer marketplace."

Wunderman New York currently handles the Arimidex and Casodex/Zoladex brands, which are part of AstraZeneca's oncology medications.

A print campaign for Faslodex will begin this summer. Call to action and theme have not yet been disclosed.

Share this article:
You must be a registered member of Direct Marketing News to post a comment.

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

More in Agency

Mohegan Sun Bets on an Integrated Customer Experience

Mohegan Sun Bets on an Integrated Customer Experience

Casino and entertainment destination Mohegan Sun went all-in and overhauled its website to improve its guest experience online and on-site. The casino's payoff was big.

Former Lenovo Executive to Head Digital Marketing at Interakt

Former Lenovo Executive to Head Digital Marketing at ...

Elijah Degen brings 15 years of experience to his new role at the digital agency.

Analytics Is a CMO's Best Friend

Analytics Is a CMO's Best Friend

CMOs who want to extend their tenure should embrace analytics to improve marketing performance and enable innovation.